Tax included.
The Pharma Legal Handbook: Medical Cannabis, Cannabinoids & Opioids answers essential questions about the legal and regulatory environment for medical cannabis, cannabinoids, and opioid drugs in 39 countries:
Algeria, Argentina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Ecuador, Egypt, Germany, Greece, India, Indonesia, Japan, Luxembourg, Malaysia, Mexico, Nigeria, Norway, Panama, Peru, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovakia, South Africa, Spain, Switzerland, Thailand, Ukraine, Uruguay and Venezuela .
Prepared in association with leading local law firms and consultancies, it is a must-have for any company operating in or looking to enter these niches in any of these countries.
Publisher: White Publishing Resources
333 pages
Partner Companies:
Algeria (SAARPE)
Argentina (Marval O'Farrall & Mairal)
Brazil (Trench Rossi Watanabe)
Canada (Fasken)
Chile (Carey)
Colombia (Cavalier Abogados)
Croatia (Danijel Probanic)
Czech Republic (PRK Partners)
Denmark (Gorrissen Federspiel)
Ecuador (CorralRosales)
Egypt (Youssry Saleh)
Germany (Heuking Kühn Lüer Wojtek)
Greece (Calavros Law Firm)
India (Nishith Desai Associates)
Indonesia (ABNR)
Japan (Nishimura & Asahi)
Luxembourg (Wildgen)
Malaysia (Skrine)
Mexico (OLIVARES)
Nigeria (Olaniwun Ajayi LP)
Panama (Alfaro, Ferrer y Ramirez (AFRA))
Peru (Osterling Abogados)
Portugal (Cuatrecasas)
Romania (Mușat & Asociații)
Russia (Lidings)
Singapore (Drew & Napier)
Slovakia (PRK Partners)
South Africa (Fasken)
Spain (Faus & Moliner Abogados)
Thailand (Tilleke & Gibbins)
Ukraine (Sayenko Kharenko)
Uruguay (Ferrere)
Publication Date: September 2019
Updated: March 2020